MARKET

BCTX

BCTX

BriaCell
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.19
+0.91
+10.99%
After Hours: 9.26 +0.07 +0.76% 19:59 09/24 EDT
OPEN
8.20
PREV CLOSE
8.28
HIGH
9.45
LOW
8.12
VOLUME
10.05M
TURNOVER
--
52 WEEK HIGH
9.45
52 WEEK LOW
2.815
MARKET CAP
140.33M
P/E (TTM)
-9.1534
1D
5D
1M
3M
1Y
5Y
BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com
BriaCell Therapeutics CEO Interview BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com AUSTIN, Texas, Sept. 23, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new ...
GlobeNewswire · 2d ago
BRIEF-BriaCell Announces TSXV Acceptance Of Normal Course Issuer Bid
reuters.com · 3d ago
BriaCell Announces TSXV Acceptance of Normal Course Issuer Bid
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, today announces that the TSX Venture Exchange (the "TS...
GlobeNewswire · 3d ago
Briacell's Survival Story Could Mean a Better Chance of Survival for Women Suffering from Breast Cancer
Photo by Artem Podrez from Pexels
Benzinga · 3d ago
BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces today that the Company will be presenting at...
GlobeNewswire · 09/16 13:00
BRIEF-Briacell To Buy Back Up To 10% Of Common Shares, 10% Of Listed Warrants
reuters.com · 09/09 14:06
BriaCell Announces Securities Buyback to Purchase up to 10% of Common Shares and up to 10% of Listed Warrants
BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapi...
GlobeNewswire · 09/09 13:00
BRIEF-Briacell Therapeutics Appoints Marc Lustig To Board Of Directors
reuters.com · 09/01 13:17
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BCTX. Analyze the recent business situations of BriaCell through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.13%
Pharmaceuticals & Medical Research
-1.02%
Key Executives
Chairman/Director
Jamieson Bondarenko
President/Chief Executive Officer/Director
William Williams
Chief Financial Officer/Secretary
Gadi Levin
Director
Marc Lustig
Independent Director
Vaughn Embro-Pantalony
Independent Director
Martin Schmieg
Independent Director
Rebecca Taub
No Data
About BCTX
BriaCell Therapeutics Corp. is a Canada-based immuno-oncology focused biotechnology company developing targeted approaches for the management of cancer. The Company, in collaboration with Incyte Corporation, is conducting a Phase I/IIa clinical trial of Bria-IMT in combination with Incyte drugs, INCMGA00012 and epacadostat, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing. Bria-OTS is designed to produce a potent and selective immune response against the cancer of each patient while eliminating the time, expense and manufacturing logistics associated with other personalized immunotherapies.

Webull offers kinds of Briacell Therapeutics Corp stock information, including NASDAQ:BCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BCTX stock methods without spending real money on the virtual paper trading platform.